探讨学派宗师彭静山教授"观眼识病"理论内涵.彭老以王肯堂《证治准绳·目门》记载的眼与脏腑关系及验目理论为基础,以脏腑学说、经络学说及五轮八廓等理论为指导,强调眼与人体之间的内在联系,通过临床上万次病例观察总结五脏六腑的生理病理情况在白睛对应分区上形色脉络显现规律,该理论与现代医学中球结膜微循环理论有较强的一致性.应用"观眼识病"理论对白睛络脉形、色、丝络变化的观察能诊察疾病,不仅扩展了中医望、闻、问、切的诊察范围,而且加强了四诊的针对性与可行性,填补中医望诊的空白.

辽宁彭氏眼针学术流派宗师彭静山教授首创"眼针疗法",其理论源于王肯堂《证治准绳·目门》记载的眼与脏腑关系及五轮八廓学说.彭静山嫡传弟子王鹏琴教授通过国家 973 课题及多年临床研究,总结挖掘眼针疗法理论为"眼针八区十三穴络脑通脏腑",眼-经络-脑-脏腑紧密联系,眼针通过针刺眼眶周围特定穴位治疗全身疾病,应用于临床治疗疾病40 余年,临床疗效确切,中风病及痛症为其优势病种.文章深入探讨分析眼针疗法核心理论,挖掘整理本流派学术思想体系,传承发展流派核心技术.

Eye acupuncture with acupuncture rehabilitation therapy refers to the organic combination of eye acupuncture therapy and modern rehabilitation technology. According to the different functional disorders of rehabilitation objects, the corresponding acupoints of "Eight Areas and Thirteen Points of Eye Acupuncture" were selected to bury the needles, and various rehabilitation training were carried out simultaneously during the needle retention period. The main purpose of establishing the operational standard for eye acupuncture with acupuncture rehabilitation therapy is to standardize management and guide the professionals and technical personnel of traditional Chinese medicine to correctly use the eye acupuncture and acupuncture rehabilitation therapy for rehabilitation treatment. This standard includes the technical scope of eye acupuncture and acupuncture rehabilitation therapy, normative references, terminology and definitions (eye acupuncture physical therapy, eye acupuncture occupational therapy, eye acupuncture speech training, eye acupuncture cognitive rehabilitation training, eye acupuncture pain rehabilitation techniques), operating procedures and requirements (selection of eye acupuncture needles, acupoint selection principle, body position selection, environmental requirements and operation methods, etc.), main indications, contraindications, precautions and other aspects. This operational standard could be applied to guide the professionals and technical personnel of traditional Chinese medicine in hospitals at all levels and medical and health care institutions to carry out eye acupuncture with acupuncture rehabilitation therapy, with wide generality and effectiveness.

目的:探究清热活血解毒方联合改良挂线术治疗瘘管期浆细胞性乳腺炎临床疗效.方法:选取86例瘘管期浆细胞性乳腺炎患者为研究对象,随机分为对照组(n=43)和治疗组(n=43).对照组给予改良挂线术治疗,治疗组给予清热活血解毒方联合改良挂线术治疗,观察两组治疗前后临床症状、血清免疫球蛋白IgG、IgM、IgA以及炎症因子水平变化,评估两组临床疗效和安全性.结果:治疗后两组乳房胀痛、乳房肿胀、乳头溢液症状评分均降低,且治疗组各评分低于对照组,差异有统计学意义(均P<0.05).治疗后两组IgG、IgM、IgA水平均降低,且治疗组低于对照组,差异有统计学意义(均P<0.05).治疗后两组IL-1、IL-6、TNF-α水平均降低,且治疗组低于对照组,差异有统计学意义(均P<0.05).治疗组总有效率高于对照组,而不良反应发生率、复发率低于对照组,差异有统计学意义(均P<0.05).结论:清热活血解毒方联合改良挂线术治疗瘘管期浆细胞性乳腺炎患者能有效缓解患者临床症状,改善免疫功能,减轻炎症反应,减少不良反应,疗效较好.

目的:研究平消胶囊含药血清联合紫杉醇对乳腺癌细胞的作用及机制.方法:用平消胶囊灌喂大鼠以制备平消胶囊含药血清,分别用无药血清、平消胶囊含药血清、紫杉醇、平消胶囊含药血清联合紫杉醇处理乳腺癌MCF-7细胞株,分别依次为对照组、含药血清组、紫杉醇组、联合组.用MTT实验检测药物对乳腺癌细胞的抑制效果;用流式细胞仪检测细胞凋亡情况及周期变化;采用蛋白印迹法检测Bax、Bcl-2、Caspase-3、AMPK和P21蛋白的表达量.结果:与对照组相比,含药血清组、紫杉醇组和联合组中细胞增殖力均被显著抑制,但联合组更明显(P＜0.05).流式细胞仪检测结果显示,与对照组相比,含药血清组、紫杉醇组和联合组肿瘤细胞周期G0/G1发生阻滞,细胞凋亡率增大,但联合组效果更显著(P＜0.05).与对照组相比,含药血清组、紫杉醇组和联合组中Bcl-2蛋白均显著下调(P＜0.05),Bax和Caspase-3、AMPK和P21蛋白上调,联合组的效果更显著(P＜0.05).结论:平消胶囊含药血清联合紫杉醇可能通过激活AMPK信号通路,诱导凋亡,从而抑制乳腺癌细胞增殖.

新型冠状病毒感染的肺炎目前在世界范围内流行,给人民生产生活和身体健康构成严重威胁,各中西医结合医院普外科为防控需要原有诊疗模式发生改变,如何做好疫情防控前提下,让普外科疾病患者得到合理诊治.本文就新冠肺炎非疫区复工复产下患者门诊就诊、住院流程的建立、医护人员防护、病房的合理化分配、患者术后发热处理流程、确诊及疑似新冠肺炎患者的术中及围手术期处理等方面探讨诊疗策略,并在疾病围手术期使用中医药治疗促进患者快速恢复,体现中西医结合对普外科疾病的治疗优势.

[目的]观察一效散治疗老年腹部手术切口脂肪液化疗效.[方法]使用随机平行对照方法,将30例住院患者按病志号抽签/就诊顺序号方法随机分为两组;术区常规治疗,拆除局部缝合线,排出液化脂肪及渗出物.对照组15例彻底清创后内置胶皮引流条,待新鲜肉芽组织生长后,用蝶形胶布合拢切口.治疗组15例一效散(炉甘石煅,朱砂,冰片,滑石粉)调和适量香油,平铺于纱布,填充残腔.连续治疗4周为1疗程.观测临床症状、切口愈合时间、不良反应.治疗1疗程,判定疗效.[结果]切口愈合时间治疗组优于对照组(P＜0.01).[结论]一效散治疗老年腹部手术切口脂肪液化,疗效满意,改善愈合时间,无严重不良反应,值得推广.